Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients

Scand J Rheumatol. 2010 Nov;39(6):518-20. doi: 10.3109/03009741003781969. Epub 2010 Jun 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / genetics
  • Genetic Association Studies
  • Humans
  • Infliximab
  • Polymorphism, Single Nucleotide
  • Receptors, IgG / genetics*
  • Severity of Illness Index
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / genetics

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • FCGR3A protein, human
  • Receptors, IgG
  • Infliximab